Serum Galectin-3 and Glial Fibrillary Acidic Protein Levels in Patients with Spinal Cord Injury in Relation to Injury Severity and Prognosis

Key Points

• The study aims to evaluate the relationship between serum galectin-3 and GFAP levels with the severity of spinal cord injury and its prognosis over six months.
• Measured serum Gal-3 and GFAP levels in spinal cord injury patients at admission.
• Analyzed the association of these biomarkers with injury severity and outcomes after six months.
• Used clinical assessments to evaluate injury severity and prognosis.
• There is a significant association between serum Gal-3 levels and injury severity at admission.
• GFAP levels also correlate significantly with the prognosis after six months.
• Both biomarkers can serve as clinical risk factors for predicting outcomes in SCI.